Stay updated on DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial
Sign up to get notified when there's something new on the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page.

Latest updates to the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page
- Check2 days agoChange DetectedThe study record is now available, with details on the DX-2930 trial’s design, eligibility criteria, locations, interventions, outcomes, and publication history.SummaryDifference59%

- Check9 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0. The study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA site-wide NIH notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the 403 error page remains unchanged.SummaryDifference0.2%

- Check30 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision: v3.7.0 was applied, and a broad set of terms related to the study's drug, disease, and metadata were removed. The change alters how the study is described and indexed on the page.SummaryDifference19%

Stay in the know with updates to DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page.